HF
GRI

HRT Financial’s GRI Bio GRI Stock Holding History

HRT Financial’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50K Buy
+28,784
New +$63.8K ﹤0.01% 3777
2024
Q4 		– Sell
-29
Closed -$5K – 2705
2024
Q3 		$5K Buy
+29
New +$11.7K ﹤0.01% 2269
2024
Q2 		– Sell
-3
Closed -$14K – 2535
2024
Q1 		$14K Buy
3
+2
+200% +$17.1K ﹤0.01% 2038
2023
Q4 		$9K Buy
+1
New +$41.7K ﹤0.01% 2090

Other funds holding GRI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

HRT Financial's GRI Position: Q2 2026 in Review

HRT Financial opened a new position in GRI Bio (GRI) in Q2 2026: 28,784 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #3777 among its holdings. This is a return to the name: HRT Financial previously reported a position in GRI as recently as Q3 2024.

HRT Financial first reported a position in GRI in Q4 2023 and has held it in 4 quarters since. 11 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • HRT Financial held 28,784 shares of GRI Bio worth $50K as of Q2 2026.
  • GRI Bio was a new HRT Financial position in Q2 2026.
  • GRI Bio made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3777 holding.
  • HRT Financial first reported a position in GRI Bio in Q4 2023 and has held it in 4 quarters since.
  • 11 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.